Work

A phase II study of cabozantinib in metastatic castration-resistant prostate cancer (mCRPC) with visceral metastases (VM) with very small nuclear circulating tumor cell (vsnCTC) association studies.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.2_suppl.208

Authors: Richard Huynh, Jie-Fu Chen, Mourad Tighiouart, Margarit Sievert, Amy Oppenheim, Nancy P. Moldawer, Beatrice Knudsen, Michael Freeman, Neil Bhowmick, Andre Rogatko, Hsian-Rong Tseng, Leland WK Chung, Kevin Scher, Robert A. Figlin, Edwin M. Posadas

Institutions: Cedars-Sinai Medical Center, University of California, Los Angeles

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2591247283

Cites:

Cited by: 2

Related to: 10